Latest Product Development News

Ava Risk Group has appointed Bryant Henson as CEO to spearhead its next growth phase, with a sharp focus on expanding its footprint in the United States and strengthening commercial execution worldwide.

ANZ has completed the acquisition of Worldline S.A’s 51% stake in ANZ Worldline, gaining full ownership of its merchant payments business and integrating around 270 employees as part of its 2030 strategic vision.

Singular Health deepens US healthcare foothold with ongoing Triple-S contract talks, PNS licence expansion, and Miami-Dade educational rollout, supported by a solid $10.1 million cash reserve.

Boresight Ltd (ASX: BST) marked its ASX debut in June with a successful $8 million IPO, reporting a 55% revenue increase in FY26 and securing a major US manufacturing expansion to meet rising defence drone demand.

4DMedical has secured a pivotal three-year contract with SimonMed Imaging to deploy its CT:VQ™ lung imaging technology across over 170 US outpatient centres, while FY26 revenue rose 23% to $7.2 million on record scan volumes and global expansion.

Decidr AI Industries accelerated its commercial growth with a 71% jump in annualised exit-rate revenue to $13.6 million and bolstered its cash position to $23.4 million following a $14.2 million equity raise.

Pointerra Limited boosted its FY26 performance with a 33% rise in Q4 customer receipts and multi-year contracts from top utilities, underpinning improved cashflow and platform expansion.

BluGlass capped FY26 with major contract wins including a $1.4 million Phase II deal with Uviquity, a $1.3 million agreement with a Fortune 500 data storage giant, and a world-record 1.9W output from its blue GaN laser, while raising $14.6 million to fuel growth.

Jindalee Lithium is pushing ahead with its McDermitt Lithium Project in the US, securing shareholder approval for a NASDAQ listing via US Elemental and raising $10.9 million to fund drilling and testwork. The project aims to deliver both lithium and magnesium, aligning with US critical minerals priorities.

Swift TV Limited has completed its transition from development to commercial rollout, securing Google certification and Netflix approval while expanding contracts across aged care, hospitality, and workforce accommodation.

Zelira Therapeutics has raised nearly US$33 million into its HOPE® 1 special purpose vehicle, valuing the SPV at about US$66 million post-money. The funds will advance FDA regulatory submissions and Phase 1 clinical trials for its autism-targeting cannabinoid drug.

Raiz Invest reported robust Q4 FY26 growth with active customers climbing 6.7% and funds under management hitting $2.32 billion, while confirming FY26 profitability guidance.